These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Controlled trial of amantadine hydrochloride in Parkinson's disease. Jorgensen PB; Bergin JD; Haas L; Cuningham JA; Morah DD; Pollock M; Robinson RG; Spears GF N Z Med J; 1971 May; 73(468):263-7. PubMed ID: 4932146 [No Abstract] [Full Text] [Related]
4. Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease. Silver DE; Sahs AL Trans Am Neurol Assoc; 1971; 96():307-8. PubMed ID: 4945919 [No Abstract] [Full Text] [Related]
7. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel). Merrick EM; Schmitt PP Curr Ther Res Clin Exp; 1973 Aug; 15(8):552-8. PubMed ID: 4200529 [No Abstract] [Full Text] [Related]
8. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease. Schwab RS; England AC Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453 [No Abstract] [Full Text] [Related]
9. Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial. Appleton DB; Eadie MJ; Sutherland JM Med J Aust; 1970 Oct; 2(14):626-9. PubMed ID: 4920572 [No Abstract] [Full Text] [Related]
11. Livedo reticularis in Parkinson's disease patients treated with amantadine hydrochloride. Silver DE; Sahs AL Neurology; 1972 Jul; 22(7):665-9. PubMed ID: 4673247 [No Abstract] [Full Text] [Related]
12. Treatment of Parkinson's Disease with levodopa and amantadine used as single drugs and in combined therapy. Callagham N; Mcllroy M; O'Connor M Ir J Med Sci; 1974 Mar; 143(2):67-78. PubMed ID: 4617744 [No Abstract] [Full Text] [Related]
13. Use of amantadine in Parkinson's disease. Results of a double-blind trial. Dallos V; Heathfield K; Stone P; Allen FA Br Med J; 1970 Oct; 4(5726):24-6. PubMed ID: 4919119 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Parkinson's disease with amantadine and L-Dopa. Rinne UK; Sonninen V; Siirtola T Eur Neurol; 1972; 7(4):228-40. PubMed ID: 4556618 [No Abstract] [Full Text] [Related]
15. L-dopa and amantadine hydrochloride in Parkinson's disease. Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417 [No Abstract] [Full Text] [Related]
16. Comparison of amantadine, placebo, and levodopa in Parkinson's disease. Bauer RB; McHenry JT Neurology; 1974 Aug; 24(8):715-20. PubMed ID: 4858417 [No Abstract] [Full Text] [Related]
18. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)]. Gerstenbrand F; Grünberger J; Oberhummer I Wien Med Wochenschr; 1971 May; 121(19):390-7. PubMed ID: 5559920 [No Abstract] [Full Text] [Related]
19. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)]. Gerstenbrand F; Grünberger J; Oberhummer I HNO; 1970 Nov; 18(11):390-7. PubMed ID: 5512006 [No Abstract] [Full Text] [Related]
20. Amantadine hydrochloride in the treatment of Parkinson's disease. Gilligan BS; Veale J; Wodak J Med J Aust; 1970 Oct; 2(14):634-7. PubMed ID: 4920573 [No Abstract] [Full Text] [Related] [Next] [New Search]